Supply of Moxifloxacin Hydrochloride Tablets
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
AI Contract Overview
This subcontract involves the procurement of pharmaceutical-grade Moxifloxacin Hydrochloride Tablets, 400 MG, provided in bottles of 30 tablets. The supplies are intended for prime contractors supporting Department of Defense Medical Supply Chain Pharm contracts. All medications must be delivered in sealed unit containers and strictly adhere to Medical Marking Standard No. 1, ASTM D3951, and RP001 DLA Packaging Requirements to ensure proper marking and packaging for DLA acceptance. The contract is managed by the Medical Supply Chain Pharm FSA under NAICS code 325412, with the place of performance located in Williamsburg, Virginia. Interested parties must submit responses by October 5, 2026, following the posting date of September 28, 2026.
General Info
Place of Performance
WILLIAMSBURG, VA, 23185, USASet-Aside
Documents
This scope was carved out of SPE2DP-26-T-5291.
The full solicitation package (1 document), including the RFP, is on the prime solicitation, not on this scope.
MOXIFLOXACIN HYDROC
AI Contract Breakdown
Uniform Contract FormatNo documents to break down
The breakdown needs solicitation documents. None were found from this contract's source.
Timeline
Response Deadline
Organization & Contact Information
Full Description
Similar Contracts
Same NAICS industry code
More opportunities from Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA
Same awarding agency
Ready to Pursue This Opportunity?
Get AI-powered intelligence on this solicitation and the ones like it
Every page of the solicitation package shredded into a compliance breakdown
AI-powered matching based on your capabilities and past performance
Competitor and incumbent history on the requirement
Automated alerts on amendments, Q&A deadlines, and award
Join 750+ contractors already using CLEATUS
